Human medicines European public assessment report (EPAR): Erelzi, etanercept, Date of authorisation: 23/06/2017, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Stocrin, efavirenz, Date of authorisation: 28/05/1999, Revision: 49, Status: Withdrawn

European Medicines Agency's data protection notice for use of Microsoft Intune for personal and corporate-owned devices

Financial management and budgetary reporting

Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 May 2026, European Medicines Agency, Amsterdam, the Netherlands, from 4 May 2026 to 7 May 2026

Q&A clinic on Substance, Organisation, Referentials Management Services - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026, 11:00 (CEST) to 14 April 2026, 12:00 (CEST)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 11:00 (CEST) to 12 May 2026, 12:00 (CEST)

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 15:00 (CEST) to 12 May 2026, 16:00 (CEST)

Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Date of authorisation: 21/09/2018, Revision: 14, Status: Authorised